Long-Term Visual Outcomes in Neovascular Age-Related Macular Degeneration Eyes With Baseline Macular Atrophy on Anti-Vascular Endothelial Growth Factor Treatment

BACKGROUND AND OBJECTIVE: This study explores the connection between macular atrophy (MA) status at baseline and best visual acuity (BVA) after 5 to 7 years of anti-vascular endothelial growth factor (anti-VEGF) injections on eyes with neovascular age-related macular degeneration (nAMD)

Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging retina. - 2013. - 54(2023), 4 vom: 01. Apr., Seite 223-230
1. Verfasser: Foster, Michael J (VerfasserIn)
Weitere Verfasser: Shaia, Jacqueline, Maatouk, Christopher M, Urbano, Catherine A, Bui, Mark T, Hom, Grant L, Kuo, Blanche L, Singh, Rishi P, Talcott, Katherine E
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Ophthalmic surgery, lasers & imaging retina
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Ranibizumab ZL1R02VT79 Angiogenesis Inhibitors Vascular Endothelial Growth Factor A Endothelial Growth Factors